David Raben

BCAX

David Raben serves as officer: Chief Medical Officer at Bicara Therapeutics Inc. Common Stock (BCAX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$916.6K

Net Position

Net Seller

$916.6K

Companies Traded

BCAX

Active Period

Oct 2025 – Mar 2026

3 total trades

Most Recent

Sell BCAX

Mar 5, 2026 · $305.6K

David Raben's Insider Trading at Bicara Therapeutics Inc. Common Stock (BCAX)

Buys

0 · $0.00

Sells

3 · $916.6K

Total Shares Bought

Total Shares Sold

49,500

BCAX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 5, 2026	Sell	16,500	$18.52	$305.6K	55,286
Nov 24, 2025	Sell	11,000	$18.65	$205.1K	0
Oct 9, 2025	Sell	22,000	$18.45	$405.9K	0

Related Insiders

Claire Mazumdar

director, officer: Chief Executive Officer

BCAXSell · Mar 6, 2026

Ryan Cohlhepp

President and COO

BCAXSell · Mar 5, 2026

Ivan Hyep

officer: Chief Financial Officer

BCAXSell · Mar 5, 2026

RA CAPITAL MANAGEMENT, L.P.

director, 10 percent owner:

BCAXBuy · Mar 2, 2026

Lara Meisner

Chief Legal Officer

BCAXSell · Sep 29, 2025

Explore More Insider Trading Data

BCAX Insider Trading Activity

View all insider trades at Bicara Therapeutics Inc. Common Stock

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity